RGA Q4 Deep Dive: Strategic In-Force Actions and Investment Performance Drive Results

Global life reinsurance provider Reinsurance Group of America (NYSE:RGA) announced better-than-expected revenue in Q4 CY2025, with sales up 23.6% year on year to $6.79 billion. Its non-GAAP profit of $7.75 per share was 34.8% above analysts’ consensus estimates.

Is now the time to buy RGA? Find out in our full research report (it’s free for active Edge members).

StockStory’s Take

Reinsurance Group of America’s fourth quarter was characterized by broad-based strength across regions, as management pointed to favorable in-force management actions and robust variable investment income as key contributors. CEO Tony Cheng highlighted the U.S. segment’s performance, noting that individual life mortality aligned with expectations, while EMEA and Asia-Pacific benefited from strong volume growth and product development. The company also cited the positive impact of recently acquired business blocks, particularly from the Equitable transaction, and ongoing portfolio repositioning. Management attributed these factors to the company’s ability to deliver a quarter that exceeded Wall Street’s expectations.

Looking forward, management’s guidance is underpinned by targeted capital deployment and a focus on operational execution, particularly in premium growth and risk-adjusted returns from recent transactions. CFO Axel Andre outlined expectations for improved U.S. group business following significant repricing and flagged a more measured contribution from in-force management actions. Management also emphasized ongoing investments in Asia and EMEA as well as continued balance sheet optimization, stating, “We are reiterating our intermediate-term 8% to 10% EPS growth target.” The company intends to maintain a balanced approach to capital allocation, supporting both growth initiatives and shareholder returns.

Key Insights from Management’s Remarks

Management credited the quarter’s outperformance to proactive balance sheet management, strong investment results, and the integration of new business blocks, while also addressing strategic repositioning in certain segments.

• In-force management actions: Management highlighted the impact of ongoing in-force management actions, such as liability optimization and repricing, which drove earnings and enhanced the company’s risk profile. These actions, though unpredictable in timing and magnitude, contributed significant short-term financial benefit and improved future value.
• Variable investment income: The company’s alternative investment portfolio outperformed, with variable investment income exceeding expectations. This was driven mainly by higher returns from limited partnership holdings, which management noted as a positive but acknowledged variability in future quarters due to market and real estate dynamics.
• Equitable block performance: The recently acquired Equitable block was a key earnings driver, performing in line with expectations and benefitting from repricing, asset repositioning, and operational efficiencies. Management stated the block would provide additional upside as it fully ramps up in future periods.
• APAC and EMEA momentum: Asia-Pacific and EMEA regions delivered strong bottom-line growth, aided by favorable underwriting experience and product development tailored to local market needs. In Japan and Korea, regulatory changes and robust client demand for risk transfer solutions supported new business opportunities.
• Exit from U.S. group health: Following a strategic review, RGA decided to exit its U.S. group health care lines, citing limited strategic alignment and earnings contribution. The exit, paired with recent repricing actions, aims to improve segment profitability and focus capital on higher-return opportunities.

Drivers of Future Performance

RGA’s outlook for the coming year hinges on improved group business results, disciplined capital deployment, and sustained growth in new and existing markets.

• Improved U.S. group business: Management expects the fully repriced U.S. group health block to show significant improvement in 2026, reversing previous headwinds and aligning earnings with historical norms. This turnaround is a central assumption in their forward guidance.
• Measured in-force action contributions: While recent years saw elevated earnings from in-force management, management projects a more limited impact moving forward, acknowledging the unpredictability of these actions but underscoring their ongoing strategic value.
• Continued global growth initiatives: The company plans to deploy approximately $1.5 billion in capital toward new in-force transactions and pursue growth in Asia-Pacific and EMEA. Management is also focused on leveraging external partnerships and internal expertise to enhance asset and biometric risk solutions, while maintaining a balanced capital return policy.

Catalysts in Upcoming Quarters

As we look ahead, the StockStory team will monitor (1) the pace and earnings impact of capital deployed into new in-force transactions, (2) the profitability improvement from repricing and the exit of the U.S. group health segment, and (3) the contribution of variable investment income amid market fluctuations. We will also watch for execution on growth initiatives in Asia-Pacific and EMEA as important indicators of strategic progress.

Reinsurance Group of America currently trades at $226.64, up from $205.99 just before the earnings. Is the company at an inflection point that warrants a buy or sell? The answer lies in our full research report (it’s free).

High Quality Stocks for All Market Conditions

The market’s up big this year - but there’s a catch. Just 4 stocks account for half the S&P 500’s entire gain. That kind of concentration makes investors nervous, and for good reason. While everyone piles into the same crowded names, smart investors are hunting quality where no one’s looking - and paying a fraction of the price. Check out the high-quality names we’ve flagged in our Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).

Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.